Homocyst(e)ine and the C677T mutation of methylenetetrahydrofolate reductase in survivors of premature myocardial infarction

Clinical Biochemistry

Volumn 33, Issue 6, 2000, Pages 509-512

  Virgos, Carmen ^a,b   Joven, Jorge ^a   Simó, Josep M ^a   Vilella, Elisabet ^a,b   Camps, Jordi ^a   Arcelus, Rosa ^c   Blanco Vaca, Francisco ^c   Figuera, Lídia ^a,b   Martorell, Lourdes ^a,b  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b IISPV   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ADULT; ARTICLE; CORONARY RISK; DIAGNOSTIC VALUE; GENE MUTATION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0033740460     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(00)00151-X     Document Type: Article

References (10)

1. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
2. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
3. The mutation Ala677OVal in the methylene tetrahydrofolate reductase gene: A risk factor for arterial disease and venous thrombosis
4. Concentrations of lipids and apolipoproteins in patients with clinically well-controlled insulin-dependent and non-insulin-dependent diabetes
5. Plasma homocysteine and the methylenetetrahydrofolate reductase C677T gene variant: Lack of association with schizophrenia
6. MTHFR association with arteriosclerotic vascular disease?
7. Myocardial infarction and coronary deaths in the World Health Organization MONICA project
8. Comparison of three different plasma homocysteine assays with gas chromatography-mass spectrometry
9. Major lifestyle determinants of plasma total homocysteine distribution: The Hordaland homocysteine study
10. Modulatory impact of cardiac rehabilitation on hyperhomocysteinemia in patients with coronary artery disease and normal lipid levels